A randomized controlled trial in Australia suggested that a low dose metoprolol and aspirin for 6 weeks reduces physiological and psychological surrogate measures of cardiovascular risk in early bereavement. After assessment within 2 weeks of bereavement, spouses (n = 73) or parents (n = 12) of deceased (aged 66.1 ± 9.4 years, 55 females) were randomized to 6 weeks of daily metoprolol (25 mg) and aspirin (100 mg) treatment or placebo. Participants of the treatment group had lower levels of home systolic pressure, 24-hour average heart rate, anxiety, platelet response to arachidonic acid, and depression symptoms than placebo. No significant difference in bereavement intensity or adverse safety impact were observed. Source: https://www.sciencedirect.com/
Restricting sugar intake during the first 1,000 days from conception was associated with a lower…
Incidental coronary artery calcium (CAC) identified on routine nongated chest CT scans predicts future coronary…
The burden of modifiable cardiovascular risk factors—not just the total number of risk factors—is strongly…
Higher blood levels of the gut microbiome-derived metabolite trimethylamine N-oxide (TMAO) were independently associated with…
Moderate consumption of naturally caffeinated beverages, particularly coffee, is generally associated with a lower risk…
To reduce the risk of cognitive decline and/or dementia specifically, the WHO just released updated…
This website uses cookies.